Pharma Journalist 9027 posts 0 comments

AbbVie announced new data on upadacitinib (RINVOQ) in ulcerative colitis and risankizumab (SKYRIZI) in Crohn's disease will be presented as oral presentations at the 16th Congress of…
Read More...

LFB Plasma (www.lfbplasma.com) announced today the acquisition of the ImmunoTek Bio Center located at 4560 Lake Worth Road, Greenacres, FL 33463. LFB Plasma is part of the LFB Group, a…
Read More...

Captivate Bio, a scientific cell culture solutions provider, announced it has signed an exclusive distribution agreement with PL BioScience GmbH, a biotech company located in Aachen,…
Read More...

As part of Sanofi’s ongoing efforts to reduce the complexity of its Consumer Healthcare portfolio and accelerate its growth trajectory, the company has signed an agreement with STADA…
Read More...

CMIC Co., Ltd. and Lokavant announced that they have entered into an agreement to leverage Lokavant's predictive analytics capabilities to support CMIC's clinical operations. Lokavant…
Read More...

Natera, Inc. a pioneer and global leader in cell-free DNA (cfDNA) testing, and BGI Genomics Co., Ltd., (300676.SZ), one of the world's leading genomics companies, announced the launch…
Read More...

Pieris Pharmaceuticals, Inc. a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases,…
Read More...

Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies announced a settlement agreement with the State of New York and its participating subdivisions, including…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with…
Read More...